| Post-acute COVID-19 syndrome A Nalbandian, K Sehgal, A Gupta, MV Madhavan, C McGroder, ... Nature medicine 27 (4), 601-615, 2021 | 4422 | 2021 |
| COVID-19 and its implications for thrombosis and anticoagulation JM Connors, JH Levy Blood, The Journal of the American Society of Hematology 135 (23), 2033-2040, 2020 | 2588 | 2020 |
| Apixaban for the treatment of venous thromboembolism associated with cancer G Agnelli, C Becattini, G Meyer, A Muñoz, MV Huisman, JM Connors, ... New England Journal of Medicine 382 (17), 1599-1607, 2020 | 878 | 2020 |
| Thrombotic thrombocytopenic purpura associated with clopidogrel CL Bennett, JM Connors, JM Carwile, JL Moake, WR Bell, SR Tarantolo, ... New England Journal of Medicine 342 (24), 1773-1777, 2000 | 850 | 2000 |
| Thromboinflammation and the hypercoagulability of COVID‐19 JM Connors, JH Levy Journal of thrombosis and haemostasis 18 (7), 1559-1561, 2020 | 790 | 2020 |
| Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with … AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ... Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020 | 767 | 2020 |
| Coagulopathy of coronavirus disease 2019 T Iba, JH Levy, M Levi, JM Connors, J Thachil Critical care medicine 48 (9), 1358-1364, 2020 | 632 | 2020 |
| The unique characteristics of COVID-19 coagulopathy T Iba, JH Levy, JM Connors, TE Warkentin, J Thachil, M Levi Critical care 24, 1-8, 2020 | 560 | 2020 |
| 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 443 | 2019 |
| The coagulopathy, endotheliopathy, and vasculitis of COVID-19 T Iba, JM Connors, JH Levy Inflammation Research 69, 1181-1189, 2020 | 438 | 2020 |
| Thrombophilia testing and venous thrombosis JM Connors New England Journal of Medicine 377 (12), 1177-1187, 2017 | 419 | 2017 |
| Guidance for the treatment of deep vein thrombosis and pulmonary embolism MB Streiff, G Agnelli, JM Connors, M Crowther, S Eichinger, R Lopes, ... Journal of thrombosis and thrombolysis 41, 32-67, 2016 | 405 | 2016 |
| Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. BA Friedman, AR Frackelton Jr, AH Ross, JM Connors, H Fujiki, ... Proceedings of the National Academy of Sciences 81 (10), 3034-3038, 1984 | 288 | 1984 |
| The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute … RF Grace, SE Dahlberg, D Neuberg, SE Sallan, JM Connors, EJ Neufeld, ... British journal of haematology 152 (4), 452-459, 2011 | 262 | 2011 |
| Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth H Christou, JM Connors, M Ziotopoulou, V Hatzidakis, ... The Journal of Clinical Endocrinology & Metabolism 86 (2), 935-938, 2001 | 259 | 2001 |
| New oral anticoagulants and the cancer patient NJ Short, JM Connors The oncologist 19 (1), 82-93, 2014 | 257 | 2014 |
| Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial JM Connors, MM Brooks, FC Sciurba, JA Krishnan, JR Bledsoe, ... Jama 326 (17), 1703-1712, 2021 | 250 | 2021 |
| Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review AH Talasaz, P Sadeghipour, H Kakavand, M Aghakouchakzadeh, ... Journal of the American College of Cardiology 77 (15), 1903-1921, 2021 | 183 | 2021 |
| d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy: A Cohort Study C Kearon, FA Spencer, D O'Keeffe, S Parpia, S Schulman, T Baglin, ... Annals of internal medicine 162 (1), 27-34, 2015 | 180 | 2015 |
| 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ... The Lancet Oncology 23 (7), e334-e347, 2022 | 175 | 2022 |
